These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26883407)

  • 1. Physician Experience and Attitudes Toward Addressing the Cost of Cancer Care.
    Altomare I; Irwin B; Zafar SY; Houck K; Maloney B; Greenup R; Peppercorn J
    J Oncol Pract; 2016 Mar; 12(3):e281-8, 247-8. PubMed ID: 26883407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-physician communication about out-of-pocket costs.
    Alexander GC; Casalino LP; Meltzer DO
    JAMA; 2003 Aug; 290(7):953-8. PubMed ID: 12928475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of cost discussions between patients with cancer and oncologists.
    Zafar SY; Chino F; Ubel PA; Rushing C; Samsa G; Altomare I; Nicolla J; Schrag D; Tulsky JA; Abernethy AP; Peppercorn JM
    Am J Manag Care; 2015 Sep; 21(9):607-15. PubMed ID: 26618364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The financial burden of cancer care: do patients in the US know what to expect?
    Peppercorn J
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):835-42. PubMed ID: 25269513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient experience and attitudes toward addressing the cost of breast cancer care.
    Irwin B; Kimmick G; Altomare I; Marcom PK; Houck K; Zafar SY; Peppercorn J
    Oncologist; 2014 Nov; 19(11):1135-40. PubMed ID: 25273078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding patients' attitudes toward communication about the cost of cancer care.
    Bullock AJ; Hofstatter EW; Yushak ML; Buss MK
    J Oncol Pract; 2012 Jul; 8(4):e50-8. PubMed ID: 23180999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continental Divide? The attitudes of US and Canadian oncologists on the costs, cost-effectiveness, and health policies associated with new cancer drugs.
    Berry SR; Bell CM; Ubel PA; Evans WK; Nadler E; Strevel EL; Neumann PJ
    J Clin Oncol; 2010 Sep; 28(27):4149-53. PubMed ID: 20697077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care.
    Cherny NI; Catane R;
    Cancer; 2003 Dec; 98(11):2502-10. PubMed ID: 14635087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey.
    Schrag D; Hanger M
    J Clin Oncol; 2007 Jan; 25(2):233-7. PubMed ID: 17210946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer therapy costs influence treatment: a national survey of oncologists.
    Neumann PJ; Palmer JA; Nadler E; Fang C; Ubel P
    Health Aff (Millwood); 2010; 29(1):196-202. PubMed ID: 20048377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency contraception provision: a survey of Michigan physicians from five medical specialties.
    Xu X; Vahratian A; Patel DA; McRee AL; Ransom SB
    J Womens Health (Larchmt); 2007 May; 16(4):489-98. PubMed ID: 17521252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dying for Advice: Code Status Discussions between Resident Physicians and Patients with Advanced Cancer--A National Survey.
    Einstein DJ; Einstein KL; Mathew P
    J Palliat Med; 2015 Jun; 18(6):535-41. PubMed ID: 25984641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of cost communication in oncology: Patient attitude, provider acceptance, and outcome assessment.
    Shih YT; Chien CR
    Cancer; 2017 May; 123(6):928-939. PubMed ID: 27893929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barriers to patient-physician communication about out-of-pocket costs.
    Alexander GC; Casalino LP; Tseng CW; McFadden D; Meltzer DO
    J Gen Intern Med; 2004 Aug; 19(8):856-60. PubMed ID: 15242471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physician perspectives on Choosing Wisely Canada as an approach to reduce unnecessary medical care: a qualitative study.
    Embrett M; Randall GE
    Health Res Policy Syst; 2018 Sep; 16(1):95. PubMed ID: 30257678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most?
    Shrank WH; Joseph GJ; Choudhry NK; Young HN; Ettner SL; Glassman P; Asch SM; Kravitz RL
    Am J Manag Care; 2006 Sep; 12(9):545-51. PubMed ID: 16961443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of tumor genomics in clinical practice: an international survey among ASCO members.
    Barroso-Sousa R; Guo H; Srivastava P; James T; Birch W; Siu LL; Tew WP; Tolaney SM
    Future Oncol; 2019 Jul; 15(21):2463-2470. PubMed ID: 31238721
    [No Abstract]   [Full Text] [Related]  

  • 19. End-of-life discussions in practice: survey among Canadian radiation oncologists.
    Oh J; Dennis K; Lefresne S; Livergant J; McKenzie M
    Ann Palliat Med; 2019 Sep; 8(4):420-427. PubMed ID: 31280579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?
    Mori M; Shimizu C; Ogawa A; Okusaka T; Yoshida S; Morita T
    Oncologist; 2015 Nov; 20(11):1304-11. PubMed ID: 26446232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.